Abstract
The molecular role of hepatitis C virus (HCV) in liver disease has yet to be clarified. In this study, we analyzed the relationship of HCV replication with mRNA expression of growth factors and mutation of tumor suppressor gene, ie, transforming growth factor-β1 (TGF-β1), which promotes cirrhotic changes; TGF-α, insulin-like growth factor-II (IGF-II), which are both related to hepatocyte transformation; and tumor suppressor genep53, which is associated with HCC progression. A semiquantitative RNA polymerase chain reaction (RNA-PCR) was used to analyze genetic expression in 31 cirrhotic liver specimens from patients with HCV. In order to detect HCV replication, the minus-strand RNA of HCV, which serves as a template for the synthesis of genomic plus-strand RNA, was examined. The expression of the growth factors was semiquantified by RNA-PCR, and the mutation ofp53 was detected using PCR-single-strand conformation polymorphism. According to the semiquantitative analysis, HCV replication was not associated with the expression of TGF-β1 but was significantly so with the overexpression of TGF-α (r=0.74) and IGF-II (r=0.65) in the HCV-positive cirrhotic livers. No mutation ofp53 was recognized in any of the samples. Our investigation thus suggested that the replication of HCV might mediate the coexpression of TGF-α and IGF-II and act as a possible initiating factor for hepatocarcinogenesis.
Similar content being viewed by others
References
Wands JR, Blum HE: Hepatitis B and C virus and alcohol-induced liver injury. Hepatology 14:730–733, 1991
Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q-L, Houghton M, Kuo G: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547–6549, 1990
Wengler G: Flaviviridae.In Classification of Nomenclature of Viruses. Archives of Virology, Suppl 2. RIB Francki, CM Fauquet, DL Knudson, F Brown (eds), Wien, Springer-Verlag, 1991, pp. 223–233
Takehara T, Hayashi N, Mita E, Hagiwara H, Ueda K, Katayama K, Kasahara A, Fusamoto H, Kamada T: Detection of the minus strand of hepatitis C virus RNA by reverse transcriptase and polymerase chain reaction: Implications of hepatitis C virus replication in infected tissue. Hepatology 15:387–390, 1992
Takeda S, Shibata M, Morishima T, Harada A, Nakao A, Takagi H, Nagai Y: Hepatitis C virus infection in hepatocellular carcinoma. Cancer 1992:70:2255–2259
Gerber MA, Shieh YSC, Shim K-S, Thung SN, Demetris AJ, Schwartz M, Akyol G, Dash S: Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol 141:1271–1277, 1992
Kew MC, Popper H: Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 4:135–146, 1984
The Liver Cancer Study Group of Japan: Primary liver cancer in Japan, clicopathologic features and results of surgical treatment. Ann Surg 211:277–287, 1990
Castilla A, Prieto J, Fausto N: Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 324:933–940, 1991
Lee G-H, Merlino G, Fausto N: Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res 52:5162–5170, 1992
Mead JE, Fausto N: Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86:1558–1562, 1989
Cariani E, Lasserre C, Seurin D, Hemelin B, Kemeny F, Franco D, Czech MP, Ullrich A, Brechot C: Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res 48:6844–6849, 1988
Fu X-X, Su CY, Lee Y, Hintz R, Biempica L, Snyder R, Rogler CE: Insulinkike grwoth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers. J Virol 62:3422–3430, 1988
Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y, Rogler CE: Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 52:2549–2556, 1992
Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K: Tumor progression in hepatocellular carcinoma may be mediated byp53 mutation. Cancer Res 53:2884–2888, 1993
Orita M, Ishihara H, Kanazawa H, Hayashi H, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766–2770, 1989
Chomzynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987
Tanaka S, Toh Y, Minagawa H, Mori R, Sugimachi K, Minamishima Y: Reactivation of cytomegalovirus in patients with cirrhosis: Analysis of 122 cases. Hepatology 16:1409–1414, 1992
Funk CD, FitzGerald GA: Eicosanoid forming enzyme mRNA in human tissues. Analysis by quantitative polymerase chain reaction. J Biol Chem 266:12508–12513, 1991
Kinoshita T, Imamura J, Nagai H, Shimotohno K: Quantification of gene expression over a wide range by polymerase chain reaction. Anal Biochem 206:231–235, 1992
Bishop JM: The molecular analysis of cancer. Science 235:305–311, 1987
Fearon ER, Vogelstein BA: A genetic model for colorectal tumorigenesis. Cell 61:759–767, 1990
Ignotz RA, Massague J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337–4345, 1986
Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT: TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137–1146, 1990
Takagi H, Sharp R, Hammermeister C, Goodrow T, O'Bradley MO, Fausto N, Merlino G: Molecular and genetic analysis of liver oncogenesis in transforming growth factor α transgenic mice. Cancer Res 52:5171–5177, 1992
Fausto N: Protooncogenes and growth factors associated with normal and abnormal liver growth. Dig Dis Sci 36:653–658, 1991
Friend SH, Dryja TP, Weinberg RA: Oncogenes and tumorsuppressing genes. N Engl J Med 318:618–622, 1988
Murakami Y, Hayashi K, Hirohashi S, Sekiya T: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51:5520–5525, 1991
Hsia CC, Axiotis CA, Di Bisceglic AM, Tabor E: Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver. Cancer 70:1049–1056, 1992
Chakaraborty PR, Ruiz-Opazo N, Shouval D, Shfritz DA: Identification of integrated hepatitis B virus DNA and viral RNA in HBsAg-producing human hepatocellular carcinoma cell line, Nature 286:531–533, 1980
Brechot C, Pourcel C, Louise A, Rain B, Tiollais P: Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533–535, 1980
Edman JC, Gray P, Valenzuela P, Rall LB, Rutter WJ: Intergration of hepatitis B virus sequences and their expression in a human hepatoma cell line. Nature 286:535–538, 1980
Wang J, Chenwesse X, Henglein B, Brechot C: Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343:555–557, 1990
Dejean A, Bougueleret L, Grzeshik KH, Tiollais P: Hepatitis B virus DNA integration in a sequence homologous to V-erb-A and steroid receptor genes in hepatocellular carcinoma. Nature 322:70–72, 1986
Twu JS, Schloemer RH: Transcriptional transactivating functions of hepatitis B virus. J Virol 61:3448–3453, 1987
Kim CM, Koike KK, Saito I, Miyamura T, Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenie mice. Nature 351:317–320, 1991
Yoneyama T, Takeuchi K, Watanabe Y, Harada H, Ohbayashi A, Tanaka Y, Yuasa T, Saito I, Miyamura T: Detection of hepatitis C virus cDNA sequence by the polymerase chain reaction in hepatocellular carcinoma tissues. Jpn J Med Sci Biol 43:89–94, 1990
Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH: Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 67:5823–5832, 1993
Wang C, Sarnow P, Siddiqui A: Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal reibosome-binding mechanism. J Virol 67:3338–3344, 1993
Yoo BJ, Spaete RR, Geballe AP, Selby M, Houghton M, Han JH: 5′ end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5′ untranslated region. Virology 191:889–899, 1992
Ji H, Zhang Q, Leung BS: Survey of oncogene and growth factor/receptor gene expression in cancer cells by introndifferential RNA/PCR. Biochem Biophys Res Commun 170:569–575, 1990
Yeh J, Danehy FT, Osathanondh R, Villa-Komaroff L: mRNAs for insulin-like growth factor-II (IGF-II) and variant IGF-II are co-expressed in human fetal ovary and uterus. Mol Cell Endocrinol 80:75–82, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanaka, S., Takenaka, K., Matsumata, T. et al. Hepatitis C virus replication is associated with expression of transforming growth factor-α and insulin-like growth factor-II in cirrhotic livers. Digest Dis Sci 41, 208–215 (1996). https://doi.org/10.1007/BF02208606
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02208606